Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
82,262,152
-
Share change
-
+15,075,394
-
Total reported value
-
$1,355,589,943
-
Put/Call ratio
-
28%
-
Price per share
-
$16.48
-
Number of holders
-
296
-
Value change
-
+$248,962,456
-
Number of buys
-
149
-
Number of sells
-
86
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2023
As of 31 Mar 2023 TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) had 296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 82,262,152 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, MORGAN STANLEY, Clal Insurance Enterprises Holdings Ltd, GOLDMAN SACHS GROUP INC, Mondrian Investment Partners LTD, MACQUARIE GROUP LTD, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and Point72 Asset Management, L.P..
This table shows 296 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.